Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: +0.00% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company has neither positive free cash flow nor a collected share count, so a reverse DCF can't be run.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 2 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-08-03 · 44d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $4.5M 100.0% | $5.5M 100.0% | $6.8M 100.0% | $10.6M 100.0% | $17.0M 100.0% | $2.0M 100.0% |
| Cost of Revenue | $6.9M 151.9% | $6.6M 118.2% | $6.3M 93.3% | $9.5M 89.3% | $15.8M 92.6% | $1.1M 53.9% |
| Gross Profit | -$2.3M -51.9% | -$1.0M -18.2% | $457K 6.7% | $1.1M 10.7% | $1.3M 7.4% | $902K 46.1% |
| Research & Development | $217K 4.8% | $642K 11.6% | $853K 12.6% | $476K 4.5% | $419K 2.5% | $348K 17.8% |
| Selling, General & Admin | $2.7M 59.8% | $6.3M 112.9% | $6.8M 100.9% | $7.2M 67.5% | $2.4M 14.0% | $231K 11.8% |
| Total Operating Expenses | $4.5M 99.0% | $6.9M 124.5% | $7.8M 115.5% | $8.6M 80.9% | $17.7M 104.0% | $620K 31.7% |
| Operating Income | -$6.8M -150.9% | -$7.9M -142.7% | -$7.4M -108.8% | -$7.5M -70.2% | -$16.5M -96.6% | $282K 14.4% |
| Interest & Investment Income | — | — | — | — | $2K 0.0% | — |
| Other Income (Expense), net | $369K 8.2% | $2.0M 36.5% | $1.3M 18.5% | -$1.4M -13.0% | -$228K -1.3% | $174K 8.9% |
| Pretax Income | -$6.5M -142.7% | -$5.9M -106.2% | -$6.1M -90.3% | -$8.8M -83.1% | -$16.7M -97.9% | $456K 23.3% |
| Income Tax Expense | — | — | — | — | $24K 0.1% | $53K 2.7% |
| Net Income | -$6.5M -142.7% | -$5.9M -106.2% | -$6.1M -90.3% | -$8.8M -83.1% | -$16.7M -98.0% | $403K 20.6% |
| Per Share | ||||||
| EPS (Basic) | $-3.51 | $-3.46 | $-3.79 | $-6.72 | $-1.43 | — |
| EPS (Diluted) | $-3.51 | $-3.46 | $-3.79 | $-6.72 | $-1.43 | — |
| Weighted Avg Shares (Basic) | 1.8M | 1.7M | 1.6M | 1.3M | 12.4M | 12.4M |
| Weighted Avg Shares (Diluted) | 1.8M | 1.7M | 1.6M | 1.3M | 12.4M | 12.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
1/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 6 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -58%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 6 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $202000 is below short-term debt of $4M — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-08-03
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cost of Revenue | 53.9 | 92.6 | 89.3 | 93.3 | 118.2 | 151.9 |
| Gross Profit | 46.1 | 7.4 | 10.7 | 6.7 | -18.2 | -51.9 |
| R&D | 17.8 | 2.5 | 4.5 | 12.6 | 11.6 | 4.8 |
| SG&A | 11.8 | 14.0 | 67.5 | 100.9 | 112.9 | 59.8 |
| Operating Income | 14.4 | -96.6 | -70.2 | -108.8 | -142.7 | -150.9 |
| Income Tax | 2.7 | 0.1 | — | — | — | — |
| Net Income | 20.6 | -98.0 | -83.1 | -90.3 | -106.2 | -142.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SAIHW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.